nodes	percent_of_prediction	percent_of_DWPC	metapath
Methocarbamol—CA1—Erythrocytes take up carbon dioxide and release oxygen—CA2—osteoporosis	0.0632	0.429	CbGpPWpGaD
Methocarbamol—CA1—Reversible hydration of carbon dioxide—CA2—osteoporosis	0.0502	0.341	CbGpPWpGaD
Methocarbamol—CA1—C-MYB transcription factor network—COL1A2—osteoporosis	0.00688	0.0467	CbGpPWpGaD
Methocarbamol—CA1—C-MYB transcription factor network—WNT1—osteoporosis	0.00625	0.0424	CbGpPWpGaD
Methocarbamol—Thrombophlebitis—Conjugated Estrogens—osteoporosis	0.0055	0.00645	CcSEcCtD
Methocarbamol—Pain—Calcium Acetate—osteoporosis	0.00533	0.00625	CcSEcCtD
Methocarbamol—Conjunctivitis—Raloxifene—osteoporosis	0.00522	0.00613	CcSEcCtD
Methocarbamol—Drowsiness—Calcitriol—osteoporosis	0.00521	0.00611	CcSEcCtD
Methocarbamol—Injury—Conjugated Estrogens—osteoporosis	0.00518	0.00607	CcSEcCtD
Methocarbamol—Feeling abnormal—Calcium Acetate—osteoporosis	0.00513	0.00602	CcSEcCtD
Methocarbamol—Conjunctivitis—Calcitriol—osteoporosis	0.00506	0.00594	CcSEcCtD
Methocarbamol—Pain—Ergocalciferol—osteoporosis	0.00471	0.00552	CcSEcCtD
Methocarbamol—Hypersensitivity—Calcium Acetate—osteoporosis	0.00459	0.00538	CcSEcCtD
Methocarbamol—Angioedema—Etidronic acid—osteoporosis	0.00458	0.00537	CcSEcCtD
Methocarbamol—Leukopenia—Etidronic acid—osteoporosis	0.00449	0.00526	CcSEcCtD
Methocarbamol—Flushing—Raloxifene—osteoporosis	0.00448	0.00525	CcSEcCtD
Methocarbamol—Pruritus—Calcium Acetate—osteoporosis	0.00441	0.00517	CcSEcCtD
Methocarbamol—Thrombophlebitis—Estradiol—osteoporosis	0.0044	0.00516	CcSEcCtD
Methocarbamol—Conjunctivitis—Risedronate—osteoporosis	0.00426	0.005	CcSEcCtD
Methocarbamol—Dysgeusia—Alendronate—osteoporosis	0.00418	0.0049	CcSEcCtD
Methocarbamol—Nasal congestion—Estradiol—osteoporosis	0.00418	0.0049	CcSEcCtD
Methocarbamol—Injury—Estradiol—osteoporosis	0.00414	0.00486	CcSEcCtD
Methocarbamol—Confusional state—Etidronic acid—osteoporosis	0.00412	0.00484	CcSEcCtD
Methocarbamol—Dizziness—Calcium Acetate—osteoporosis	0.00412	0.00483	CcSEcCtD
Methocarbamol—Dysgeusia—Ibandronate—osteoporosis	0.00407	0.00478	CcSEcCtD
Methocarbamol—Amnesia—Estradiol—osteoporosis	0.00405	0.00475	CcSEcCtD
Methocarbamol—Conjunctivitis—Pamidronate—osteoporosis	0.00405	0.00475	CcSEcCtD
Methocarbamol—Dysgeusia—Calcitriol—osteoporosis	0.00399	0.00467	CcSEcCtD
Methocarbamol—Angioedema—Estropipate—osteoporosis	0.00396	0.00465	CcSEcCtD
Methocarbamol—Vomiting—Calcium Acetate—osteoporosis	0.00396	0.00465	CcSEcCtD
Methocarbamol—Angioedema—Alendronate—osteoporosis	0.0039	0.00458	CcSEcCtD
Methocarbamol—Vertigo—Estropipate—osteoporosis	0.0039	0.00457	CcSEcCtD
Methocarbamol—Vertigo—Alendronate—osteoporosis	0.00384	0.0045	CcSEcCtD
Methocarbamol—Angioedema—Ibandronate—osteoporosis	0.0038	0.00446	CcSEcCtD
Methocarbamol—Vertigo—Raloxifene—osteoporosis	0.00377	0.00443	CcSEcCtD
Methocarbamol—Syncope—Raloxifene—osteoporosis	0.00377	0.00442	CcSEcCtD
Methocarbamol—Vertigo—Ibandronate—osteoporosis	0.00374	0.00438	CcSEcCtD
Methocarbamol—Conjunctivitis—Zoledronate—osteoporosis	0.0037	0.00434	CcSEcCtD
Methocarbamol—Nausea—Calcium Acetate—osteoporosis	0.0037	0.00434	CcSEcCtD
Methocarbamol—Loss of consciousness—Raloxifene—osteoporosis	0.00369	0.00433	CcSEcCtD
Methocarbamol—Dyspepsia—Etidronic acid—osteoporosis	0.0036	0.00422	CcSEcCtD
Methocarbamol—Anaphylactic shock—Estropipate—osteoporosis	0.00354	0.00415	CcSEcCtD
Methocarbamol—Convulsion—Calcitriol—osteoporosis	0.00353	0.00414	CcSEcCtD
Methocarbamol—Bradycardia—Zoledronate—osteoporosis	0.00348	0.00408	CcSEcCtD
Methocarbamol—Flushing—Pamidronate—osteoporosis	0.00347	0.00407	CcSEcCtD
Methocarbamol—Anaphylactic shock—Ibandronate—osteoporosis	0.00339	0.00398	CcSEcCtD
Methocarbamol—Shock—Raloxifene—osteoporosis	0.00337	0.00396	CcSEcCtD
Methocarbamol—Feeling abnormal—Etidronic acid—osteoporosis	0.00337	0.00395	CcSEcCtD
Methocarbamol—Shock—Ibandronate—osteoporosis	0.00334	0.00392	CcSEcCtD
Methocarbamol—Anaphylactic shock—Calcitriol—osteoporosis	0.00332	0.0039	CcSEcCtD
Methocarbamol—Nausea—Ergocalciferol—osteoporosis	0.00327	0.00383	CcSEcCtD
Methocarbamol—Urticaria—Etidronic acid—osteoporosis	0.00325	0.00381	CcSEcCtD
Methocarbamol—Angioedema—Ethinyl Estradiol—osteoporosis	0.00321	0.00377	CcSEcCtD
Methocarbamol—Insomnia—Estropipate—osteoporosis	0.0032	0.00375	CcSEcCtD
Methocarbamol—Dysgeusia—Pamidronate—osteoporosis	0.00319	0.00374	CcSEcCtD
Methocarbamol—Flushing—Zoledronate—osteoporosis	0.00317	0.00372	CcSEcCtD
Methocarbamol—Somnolence—Estropipate—osteoporosis	0.00315	0.00369	CcSEcCtD
Methocarbamol—Angioedema—Risedronate—osteoporosis	0.00313	0.00367	CcSEcCtD
Methocarbamol—Dyspepsia—Estropipate—osteoporosis	0.00312	0.00365	CcSEcCtD
Methocarbamol—Insomnia—Raloxifene—osteoporosis	0.0031	0.00364	CcSEcCtD
Methocarbamol—Vertigo—Risedronate—osteoporosis	0.00308	0.00361	CcSEcCtD
Methocarbamol—Syncope—Risedronate—osteoporosis	0.00307	0.0036	CcSEcCtD
Methocarbamol—Insomnia—Ibandronate—osteoporosis	0.00307	0.0036	CcSEcCtD
Methocarbamol—Dyspepsia—Alendronate—osteoporosis	0.00307	0.0036	CcSEcCtD
Methocarbamol—Pain—Estropipate—osteoporosis	0.00303	0.00355	CcSEcCtD
Methocarbamol—Dyspepsia—Raloxifene—osteoporosis	0.00302	0.00354	CcSEcCtD
Methocarbamol—Hypersensitivity—Etidronic acid—osteoporosis	0.00301	0.00353	CcSEcCtD
Methocarbamol—Loss of consciousness—Risedronate—osteoporosis	0.00301	0.00353	CcSEcCtD
Methocarbamol—Insomnia—Calcitriol—osteoporosis	0.003	0.00352	CcSEcCtD
Methocarbamol—Dyspepsia—Ibandronate—osteoporosis	0.00299	0.0035	CcSEcCtD
Methocarbamol—Pain—Alendronate—osteoporosis	0.00298	0.0035	CcSEcCtD
Methocarbamol—Angioedema—Pamidronate—osteoporosis	0.00298	0.00349	CcSEcCtD
Methocarbamol—Somnolence—Calcitriol—osteoporosis	0.00295	0.00346	CcSEcCtD
Methocarbamol—Pain—Raloxifene—osteoporosis	0.00293	0.00344	CcSEcCtD
Methocarbamol—Syncope—Pamidronate—osteoporosis	0.00292	0.00343	CcSEcCtD
Methocarbamol—Leukopenia—Pamidronate—osteoporosis	0.00292	0.00342	CcSEcCtD
Methocarbamol—Dysgeusia—Zoledronate—osteoporosis	0.00291	0.00342	CcSEcCtD
Methocarbamol—Pain—Ibandronate—osteoporosis	0.0029	0.0034	CcSEcCtD
Methocarbamol—Pruritus—Etidronic acid—osteoporosis	0.00289	0.00339	CcSEcCtD
Methocarbamol—Feeling abnormal—Alendronate—osteoporosis	0.00287	0.00337	CcSEcCtD
Methocarbamol—Loss of consciousness—Pamidronate—osteoporosis	0.00286	0.00336	CcSEcCtD
Methocarbamol—Jaundice—Estradiol—osteoporosis	0.00286	0.00335	CcSEcCtD
Methocarbamol—Conjunctivitis—Estradiol—osteoporosis	0.00285	0.00334	CcSEcCtD
Methocarbamol—Pain—Calcitriol—osteoporosis	0.00284	0.00333	CcSEcCtD
Methocarbamol—Convulsion—Pamidronate—osteoporosis	0.00282	0.00331	CcSEcCtD
Methocarbamol—Urticaria—Estropipate—osteoporosis	0.00281	0.0033	CcSEcCtD
Methocarbamol—Dysgeusia—Conjugated Estrogens—osteoporosis	0.00281	0.00329	CcSEcCtD
Methocarbamol—Vision blurred—Zoledronate—osteoporosis	0.0028	0.00329	CcSEcCtD
Methocarbamol—Body temperature increased—Estropipate—osteoporosis	0.0028	0.00328	CcSEcCtD
Methocarbamol—Feeling abnormal—Ibandronate—osteoporosis	0.0028	0.00328	CcSEcCtD
Methocarbamol—Urticaria—Alendronate—osteoporosis	0.00277	0.00325	CcSEcCtD
Methocarbamol—Body temperature increased—Alendronate—osteoporosis	0.00276	0.00323	CcSEcCtD
Methocarbamol—Shock—Risedronate—osteoporosis	0.00275	0.00323	CcSEcCtD
Methocarbamol—Angioedema—Zoledronate—osteoporosis	0.00272	0.00319	CcSEcCtD
Methocarbamol—Body temperature increased—Raloxifene—osteoporosis	0.00271	0.00318	CcSEcCtD
Methocarbamol—Vision blurred—Conjugated Estrogens—osteoporosis	0.0027	0.00317	CcSEcCtD
Methocarbamol—Urticaria—Ibandronate—osteoporosis	0.0027	0.00316	CcSEcCtD
Methocarbamol—Body temperature increased—Ibandronate—osteoporosis	0.00268	0.00315	CcSEcCtD
Methocarbamol—Confusional state—Pamidronate—osteoporosis	0.00268	0.00314	CcSEcCtD
Methocarbamol—Vertigo—Zoledronate—osteoporosis	0.00267	0.00314	CcSEcCtD
Methocarbamol—Syncope—Zoledronate—osteoporosis	0.00267	0.00313	CcSEcCtD
Methocarbamol—Leukopenia—Zoledronate—osteoporosis	0.00266	0.00312	CcSEcCtD
Methocarbamol—Anaphylactic shock—Pamidronate—osteoporosis	0.00266	0.00312	CcSEcCtD
Methocarbamol—Urticaria—Calcitriol—osteoporosis	0.00264	0.00309	CcSEcCtD
Methocarbamol—Body temperature increased—Calcitriol—osteoporosis	0.00263	0.00308	CcSEcCtD
Methocarbamol—Angioedema—Conjugated Estrogens—osteoporosis	0.00262	0.00307	CcSEcCtD
Methocarbamol—Shock—Pamidronate—osteoporosis	0.00262	0.00307	CcSEcCtD
Methocarbamol—Loss of consciousness—Zoledronate—osteoporosis	0.00262	0.00307	CcSEcCtD
Methocarbamol—Hypersensitivity—Estropipate—osteoporosis	0.00261	0.00306	CcSEcCtD
Methocarbamol—Vomiting—Etidronic acid—osteoporosis	0.0026	0.00305	CcSEcCtD
Methocarbamol—Rash—Etidronic acid—osteoporosis	0.00258	0.00302	CcSEcCtD
Methocarbamol—Convulsion—Zoledronate—osteoporosis	0.00258	0.00302	CcSEcCtD
Methocarbamol—Dermatitis—Etidronic acid—osteoporosis	0.00258	0.00302	CcSEcCtD
Methocarbamol—Vertigo—Conjugated Estrogens—osteoporosis	0.00257	0.00302	CcSEcCtD
Methocarbamol—Syncope—Conjugated Estrogens—osteoporosis	0.00257	0.00301	CcSEcCtD
Methocarbamol—Hypersensitivity—Alendronate—osteoporosis	0.00257	0.00301	CcSEcCtD
Methocarbamol—Headache—Etidronic acid—osteoporosis	0.00256	0.00301	CcSEcCtD
Methocarbamol—Insomnia—Risedronate—osteoporosis	0.00253	0.00297	CcSEcCtD
Methocarbamol—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.00252	0.00295	CcSEcCtD
Methocarbamol—Pruritus—Estropipate—osteoporosis	0.0025	0.00294	CcSEcCtD
Methocarbamol—Hypersensitivity—Ibandronate—osteoporosis	0.0025	0.00293	CcSEcCtD
Methocarbamol—Hypotension—Pamidronate—osteoporosis	0.00248	0.00291	CcSEcCtD
Methocarbamol—Convulsion—Conjugated Estrogens—osteoporosis	0.00248	0.00291	CcSEcCtD
Methocarbamol—Pruritus—Alendronate—osteoporosis	0.00247	0.00289	CcSEcCtD
Methocarbamol—Dyspepsia—Risedronate—osteoporosis	0.00246	0.00289	CcSEcCtD
Methocarbamol—Confusional state—Zoledronate—osteoporosis	0.00245	0.00287	CcSEcCtD
Methocarbamol—Hypersensitivity—Calcitriol—osteoporosis	0.00245	0.00287	CcSEcCtD
Methocarbamol—Flushing—Estradiol—osteoporosis	0.00244	0.00287	CcSEcCtD
Methocarbamol—Nausea—Etidronic acid—osteoporosis	0.00243	0.00285	CcSEcCtD
Methocarbamol—Anaphylactic shock—Zoledronate—osteoporosis	0.00243	0.00285	CcSEcCtD
Methocarbamol—Insomnia—Pamidronate—osteoporosis	0.0024	0.00282	CcSEcCtD
Methocarbamol—Pruritus—Ibandronate—osteoporosis	0.0024	0.00282	CcSEcCtD
Methocarbamol—Pain—Risedronate—osteoporosis	0.00239	0.0028	CcSEcCtD
Methocarbamol—Shock—Zoledronate—osteoporosis	0.00239	0.0028	CcSEcCtD
Methocarbamol—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.00236	0.00277	CcSEcCtD
Methocarbamol—Somnolence—Pamidronate—osteoporosis	0.00236	0.00277	CcSEcCtD
Methocarbamol—Pruritus—Calcitriol—osteoporosis	0.00235	0.00276	CcSEcCtD
Methocarbamol—Dyspepsia—Pamidronate—osteoporosis	0.00234	0.00274	CcSEcCtD
Methocarbamol—Dizziness—Estropipate—osteoporosis	0.00234	0.00274	CcSEcCtD
Methocarbamol—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.00234	0.00274	CcSEcCtD
Methocarbamol—Dizziness—Alendronate—osteoporosis	0.0023	0.0027	CcSEcCtD
Methocarbamol—Shock—Conjugated Estrogens—osteoporosis	0.0023	0.0027	CcSEcCtD
Methocarbamol—Urticaria—Ethinyl Estradiol—osteoporosis	0.00228	0.00267	CcSEcCtD
Methocarbamol—Pain—Pamidronate—osteoporosis	0.00227	0.00267	CcSEcCtD
Methocarbamol—Hypotension—Zoledronate—osteoporosis	0.00227	0.00266	CcSEcCtD
Methocarbamol—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.00227	0.00266	CcSEcCtD
Methocarbamol—Dizziness—Raloxifene—osteoporosis	0.00227	0.00266	CcSEcCtD
Methocarbamol—Vomiting—Estropipate—osteoporosis	0.00225	0.00264	CcSEcCtD
Methocarbamol—Dysgeusia—Estradiol—osteoporosis	0.00225	0.00263	CcSEcCtD
Methocarbamol—Dizziness—Ibandronate—osteoporosis	0.00224	0.00263	CcSEcCtD
Methocarbamol—Rash—Estropipate—osteoporosis	0.00223	0.00262	CcSEcCtD
Methocarbamol—Dermatitis—Estropipate—osteoporosis	0.00223	0.00261	CcSEcCtD
Methocarbamol—Urticaria—Risedronate—osteoporosis	0.00222	0.00261	CcSEcCtD
Methocarbamol—Headache—Estropipate—osteoporosis	0.00222	0.0026	CcSEcCtD
Methocarbamol—Vomiting—Alendronate—osteoporosis	0.00222	0.0026	CcSEcCtD
Methocarbamol—Body temperature increased—Risedronate—osteoporosis	0.00221	0.00259	CcSEcCtD
Methocarbamol—Rash—Alendronate—osteoporosis	0.0022	0.00258	CcSEcCtD
Methocarbamol—Insomnia—Zoledronate—osteoporosis	0.0022	0.00258	CcSEcCtD
Methocarbamol—Dermatitis—Alendronate—osteoporosis	0.0022	0.00257	CcSEcCtD
Methocarbamol—Feeling abnormal—Pamidronate—osteoporosis	0.00219	0.00257	CcSEcCtD
Methocarbamol—Hypotension—Conjugated Estrogens—osteoporosis	0.00219	0.00256	CcSEcCtD
Methocarbamol—Headache—Alendronate—osteoporosis	0.00218	0.00256	CcSEcCtD
Methocarbamol—Vomiting—Raloxifene—osteoporosis	0.00218	0.00256	CcSEcCtD
Methocarbamol—Rash—Raloxifene—osteoporosis	0.00216	0.00253	CcSEcCtD
Methocarbamol—Dermatitis—Raloxifene—osteoporosis	0.00216	0.00253	CcSEcCtD
Methocarbamol—Somnolence—Zoledronate—osteoporosis	0.00216	0.00253	CcSEcCtD
Methocarbamol—Vomiting—Ibandronate—osteoporosis	0.00216	0.00253	CcSEcCtD
Methocarbamol—Headache—Raloxifene—osteoporosis	0.00215	0.00252	CcSEcCtD
Methocarbamol—Rash—Ibandronate—osteoporosis	0.00214	0.00251	CcSEcCtD
Methocarbamol—Dermatitis—Ibandronate—osteoporosis	0.00214	0.00251	CcSEcCtD
Methocarbamol—Dyspepsia—Zoledronate—osteoporosis	0.00214	0.00251	CcSEcCtD
Methocarbamol—Headache—Ibandronate—osteoporosis	0.00213	0.00249	CcSEcCtD
Methocarbamol—Insomnia—Conjugated Estrogens—osteoporosis	0.00211	0.00248	CcSEcCtD
Methocarbamol—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.00211	0.00248	CcSEcCtD
Methocarbamol—Vomiting—Calcitriol—osteoporosis	0.00211	0.00248	CcSEcCtD
Methocarbamol—Nausea—Estropipate—osteoporosis	0.0021	0.00247	CcSEcCtD
Methocarbamol—Body temperature increased—Pamidronate—osteoporosis	0.0021	0.00246	CcSEcCtD
Methocarbamol—Angioedema—Estradiol—osteoporosis	0.0021	0.00246	CcSEcCtD
Methocarbamol—Rash—Calcitriol—osteoporosis	0.00209	0.00246	CcSEcCtD
Methocarbamol—Dermatitis—Calcitriol—osteoporosis	0.00209	0.00245	CcSEcCtD
Methocarbamol—Headache—Calcitriol—osteoporosis	0.00208	0.00244	CcSEcCtD
Methocarbamol—Somnolence—Conjugated Estrogens—osteoporosis	0.00208	0.00244	CcSEcCtD
Methocarbamol—Pain—Zoledronate—osteoporosis	0.00208	0.00244	CcSEcCtD
Methocarbamol—Nausea—Alendronate—osteoporosis	0.00207	0.00243	CcSEcCtD
Methocarbamol—Hypersensitivity—Risedronate—osteoporosis	0.00206	0.00242	CcSEcCtD
Methocarbamol—Vertigo—Estradiol—osteoporosis	0.00206	0.00242	CcSEcCtD
Methocarbamol—Dyspepsia—Conjugated Estrogens—osteoporosis	0.00206	0.00241	CcSEcCtD
Methocarbamol—Syncope—Estradiol—osteoporosis	0.00206	0.00241	CcSEcCtD
Methocarbamol—Nausea—Raloxifene—osteoporosis	0.00204	0.00239	CcSEcCtD
Methocarbamol—Pruritus—Ethinyl Estradiol—osteoporosis	0.00203	0.00238	CcSEcCtD
Methocarbamol—Nausea—Ibandronate—osteoporosis	0.00202	0.00236	CcSEcCtD
Methocarbamol—Loss of consciousness—Estradiol—osteoporosis	0.00202	0.00236	CcSEcCtD
Methocarbamol—Feeling abnormal—Zoledronate—osteoporosis	0.002	0.00235	CcSEcCtD
Methocarbamol—Pain—Conjugated Estrogens—osteoporosis	0.002	0.00235	CcSEcCtD
Methocarbamol—Pruritus—Risedronate—osteoporosis	0.00198	0.00232	CcSEcCtD
Methocarbamol—Nausea—Calcitriol—osteoporosis	0.00197	0.00231	CcSEcCtD
Methocarbamol—Hypersensitivity—Pamidronate—osteoporosis	0.00196	0.0023	CcSEcCtD
Methocarbamol—Urticaria—Zoledronate—osteoporosis	0.00193	0.00226	CcSEcCtD
Methocarbamol—Body temperature increased—Zoledronate—osteoporosis	0.00192	0.00225	CcSEcCtD
Methocarbamol—Dizziness—Ethinyl Estradiol—osteoporosis	0.0019	0.00222	CcSEcCtD
Methocarbamol—Confusional state—Estradiol—osteoporosis	0.00189	0.00221	CcSEcCtD
Methocarbamol—Pruritus—Pamidronate—osteoporosis	0.00188	0.00221	CcSEcCtD
Methocarbamol—Anaphylactic shock—Estradiol—osteoporosis	0.00187	0.00219	CcSEcCtD
Methocarbamol—Urticaria—Conjugated Estrogens—osteoporosis	0.00186	0.00218	CcSEcCtD
Methocarbamol—Dizziness—Risedronate—osteoporosis	0.00185	0.00217	CcSEcCtD
Methocarbamol—Body temperature increased—Conjugated Estrogens—osteoporosis	0.00185	0.00217	CcSEcCtD
Methocarbamol—Shock—Estradiol—osteoporosis	0.00184	0.00216	CcSEcCtD
Methocarbamol—Vomiting—Ethinyl Estradiol—osteoporosis	0.00182	0.00214	CcSEcCtD
Methocarbamol—Rash—Ethinyl Estradiol—osteoporosis	0.00181	0.00212	CcSEcCtD
Methocarbamol—Dermatitis—Ethinyl Estradiol—osteoporosis	0.00181	0.00212	CcSEcCtD
Methocarbamol—Headache—Ethinyl Estradiol—osteoporosis	0.0018	0.00211	CcSEcCtD
Methocarbamol—Hypersensitivity—Zoledronate—osteoporosis	0.00179	0.0021	CcSEcCtD
Methocarbamol—Vomiting—Risedronate—osteoporosis	0.00178	0.00209	CcSEcCtD
Methocarbamol—Rash—Risedronate—osteoporosis	0.00176	0.00207	CcSEcCtD
Methocarbamol—Dermatitis—Risedronate—osteoporosis	0.00176	0.00207	CcSEcCtD
Methocarbamol—Dizziness—Pamidronate—osteoporosis	0.00176	0.00206	CcSEcCtD
Methocarbamol—Headache—Risedronate—osteoporosis	0.00175	0.00205	CcSEcCtD
Methocarbamol—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.00172	0.00202	CcSEcCtD
Methocarbamol—Pruritus—Zoledronate—osteoporosis	0.00172	0.00201	CcSEcCtD
Methocarbamol—Nausea—Ethinyl Estradiol—osteoporosis	0.0017	0.002	CcSEcCtD
Methocarbamol—Insomnia—Estradiol—osteoporosis	0.00169	0.00199	CcSEcCtD
Methocarbamol—Vomiting—Pamidronate—osteoporosis	0.00169	0.00198	CcSEcCtD
Methocarbamol—Rash—Pamidronate—osteoporosis	0.00168	0.00197	CcSEcCtD
Methocarbamol—Dermatitis—Pamidronate—osteoporosis	0.00167	0.00196	CcSEcCtD
Methocarbamol—Headache—Pamidronate—osteoporosis	0.00167	0.00195	CcSEcCtD
Methocarbamol—Somnolence—Estradiol—osteoporosis	0.00166	0.00195	CcSEcCtD
Methocarbamol—Nausea—Risedronate—osteoporosis	0.00166	0.00195	CcSEcCtD
Methocarbamol—Pruritus—Conjugated Estrogens—osteoporosis	0.00165	0.00194	CcSEcCtD
Methocarbamol—Dyspepsia—Estradiol—osteoporosis	0.00165	0.00193	CcSEcCtD
Methocarbamol—Dizziness—Zoledronate—osteoporosis	0.00161	0.00188	CcSEcCtD
Methocarbamol—Pain—Estradiol—osteoporosis	0.0016	0.00188	CcSEcCtD
Methocarbamol—Nausea—Pamidronate—osteoporosis	0.00158	0.00185	CcSEcCtD
Methocarbamol—Dizziness—Conjugated Estrogens—osteoporosis	0.00155	0.00181	CcSEcCtD
Methocarbamol—Vomiting—Zoledronate—osteoporosis	0.00154	0.00181	CcSEcCtD
Methocarbamol—Feeling abnormal—Estradiol—osteoporosis	0.00154	0.00181	CcSEcCtD
Methocarbamol—Rash—Zoledronate—osteoporosis	0.00153	0.0018	CcSEcCtD
Methocarbamol—Dermatitis—Zoledronate—osteoporosis	0.00153	0.00179	CcSEcCtD
Methocarbamol—Headache—Zoledronate—osteoporosis	0.00152	0.00178	CcSEcCtD
Methocarbamol—CA1—C-MYB transcription factor network—MYC—osteoporosis	0.00151	0.0102	CbGpPWpGaD
Methocarbamol—Vomiting—Conjugated Estrogens—osteoporosis	0.00149	0.00174	CcSEcCtD
Methocarbamol—Urticaria—Estradiol—osteoporosis	0.00149	0.00174	CcSEcCtD
Methocarbamol—Body temperature increased—Estradiol—osteoporosis	0.00148	0.00173	CcSEcCtD
Methocarbamol—Rash—Conjugated Estrogens—osteoporosis	0.00147	0.00173	CcSEcCtD
Methocarbamol—Dermatitis—Conjugated Estrogens—osteoporosis	0.00147	0.00173	CcSEcCtD
Methocarbamol—Headache—Conjugated Estrogens—osteoporosis	0.00146	0.00172	CcSEcCtD
Methocarbamol—Nausea—Zoledronate—osteoporosis	0.00144	0.00169	CcSEcCtD
Methocarbamol—Nausea—Conjugated Estrogens—osteoporosis	0.00139	0.00163	CcSEcCtD
Methocarbamol—CA1—Metabolism—FDPS—osteoporosis	0.00138	0.0094	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—PKM—osteoporosis	0.00138	0.0094	CbGpPWpGaD
Methocarbamol—Hypersensitivity—Estradiol—osteoporosis	0.00138	0.00162	CcSEcCtD
Methocarbamol—Pruritus—Estradiol—osteoporosis	0.00132	0.00155	CcSEcCtD
Methocarbamol—CA1—Metabolism—GPD2—osteoporosis	0.00131	0.00891	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—PGLS—osteoporosis	0.00131	0.00891	CbGpPWpGaD
Methocarbamol—Dizziness—Estradiol—osteoporosis	0.00124	0.00145	CcSEcCtD
Methocarbamol—CA1—Metabolism—PNP—osteoporosis	0.0012	0.00815	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—ATIC—osteoporosis	0.0012	0.00815	CbGpPWpGaD
Methocarbamol—Vomiting—Estradiol—osteoporosis	0.00119	0.0014	CcSEcCtD
Methocarbamol—Rash—Estradiol—osteoporosis	0.00118	0.00138	CcSEcCtD
Methocarbamol—Dermatitis—Estradiol—osteoporosis	0.00118	0.00138	CcSEcCtD
Methocarbamol—Headache—Estradiol—osteoporosis	0.00117	0.00137	CcSEcCtD
Methocarbamol—Nausea—Estradiol—osteoporosis	0.00111	0.0013	CcSEcCtD
Methocarbamol—CA1—Metabolism—OXCT1—osteoporosis	0.00102	0.00693	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—CA2—osteoporosis	0.00102	0.00693	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—MGLL—osteoporosis	0.000995	0.00675	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—IDH2—osteoporosis	0.000846	0.00574	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—CYP27A1—osteoporosis	0.000795	0.0054	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—ACP5—osteoporosis	0.000773	0.00525	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—TPI1—osteoporosis	0.000719	0.00488	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—P4HB—osteoporosis	0.000676	0.00459	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—GAPDH—osteoporosis	0.000664	0.00451	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—RAP1A—osteoporosis	0.000646	0.00439	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—ENO1—osteoporosis	0.000522	0.00355	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—PSMA2—osteoporosis	0.000515	0.0035	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—PSMA5—osteoporosis	0.000515	0.0035	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—CYP19A1—osteoporosis	0.000418	0.00284	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—ADCY5—osteoporosis	0.000341	0.00232	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—GPX1—osteoporosis	0.00034	0.00231	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—MTHFR—osteoporosis	0.000314	0.00213	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—POMC—osteoporosis	0.000251	0.0017	CbGpPWpGaD
